Advanced Filters
noise

arrhythmia Clinical Trials

A listing of arrhythmia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 565 clinical trials
K Kristina Scerbakovaite

The MAGiC™ Cardiac Ablation European Study

The purpose of the first phase of this feasibility study is to gather safety and performance data on MAGiC to support European marketing approval.

18 years of age All Phase N/A
Q Qi Lu, Dr.

Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation

This study is to assess the effectiveness and safety of using cryoballoon ablation comparing with anti-arrhythmic drug therapy as initial treatment for naive patients with persistent atrial fibrillation.

18 - 75 years of age All Phase N/A
Y Young Jun Park

Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

HELP-A study is a single-center, randomized, controlled trial. A total of 588 patients enrolled during the 2 years of enrollment period and followed for 1 month of follow-up period. This study aims to compare diagnostic yield between continuous ECG Patch and intermittent handheld ECG in patients with arrhythmia symptoms.

19 years of age All Phase N/A
X Xinqiao Lian

CMR-Based Prognostic Study in Patients With Cardiac Implantable Electronic Devices

Cardiac implantable electronic devices (CIEDs) are widely used to treat patients with heart failure, malignant arrhythmias, and other conditions. However, accurately identifying suitable candidates for CIED implantation remains a clinical challenge. Cardiovascular magnetic resonance imaging (CMR) provides a comprehensive assessment of cardiac structure, function, and tissue characteristics, facilitating evaluation of …

18 years of age All Phase N/A
P Paule Banville

Remote Patient Management of CIEDs

This is a Canadian multicenter randomized controlled trial to assess remote patient management. Patients will be randomized to remote patient management versus usual care, and will be stratified by RemoteView vs no RemoteView utilization, as well as by center.

18 years of age All Phase N/A
P Pablo Nery, MD

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation

A multicentre, parallel group, two arm, single-blinded randomized clinical trial, assessing the efficacy of a patient-tailored catheter ablation (CA) strategy guided by atrial scar mapping in addition to pulmonary vein isolation (PVI) when compared to PVI alone in patients with persistent atrial fibrillation (AF).

18 years of age All Phase N/A
F Fabio Biscegli Jatene, MD, PhD

FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection

The FAPO-2 study (Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection) is a prospective, interventional, non-randomized study designed to evaluate the feasibility, usability, clinical effectiveness, and cost-efficiency of a wearable-enabled remote monitoring strategy in adult cardiac patients. The intervention consists of active clinical management of patients via teleconsultations, triggered …

22 years of age All Phase N/A

BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF

This study is designed to obtain real-world clinical evidence on the safety and effectiveness of the Volt PFA System in various use cases, with a sub study designed to address additional clinical evidence needs in electrophysiology.

18 years of age All Phase N/A
H Habib I Khan

RAFT-P&A Randomized Control Trial

Atrial fibrillation (AF) is an irregular heartbeat that can cause symptoms of skipped beats, shortness of breath, stroke, or in some cases fluid in the lungs or legs. Treating AF is mostly to do with slowing the heart rate down so that the heart can get a chance to regain …

18 years of age All Phase N/A
A Amol Verma

Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?

There are 28 non-cardiology medications from multiple families costing more than $13 billion annually in Canada, categorized as 'Known' QT-prolonging medications (QTPmeds) based on very low levels of evidence. The association between many commonly used medications listed as known QTPmeds and actual major adverse cardiac events (MACE) is weak. Meanwhile, …

18 years of age All Phase N/A

Simplify language using AI